An association of HER4 expression and a favourable outcome in breast cancer patients has independently been described by Suo and colleagues [37] who found that HER4 coexpression obviously antagonises the effect of HER2 (over-)expression on the course of breast cancer disease. Here, ERBB4 is linked to breast cancer.